Anaplerotic molecules: Current and future

Journal of Inherited Metabolic Disease

Volumn 29, Issue 2-3, 2006, Pages 327-331

  Brunengraber, Henri ^a   Roe, Charles R ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; AMINO ACID; GLUTAMIC ACID; GLUTAMINE; HEPTANOIC ACID DERIVATIVE; KETONE BODY; LACTIC ACID; PROPIONIC ACID; PROPIONYL COENZYME A; PYRUVIC ACID; VALERIC ACID DERIVATIVE;

ANAPLEROSIS; ARTICLE; BIOSYNTHESIS; CATALYSIS; CITRIC ACID CYCLE; CONGESTIVE HEART FAILURE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; DRUG POTENCY; GLUCONEOGENESIS; HUMAN; METABOLIC BALANCE; METABOLIC DISORDER; METABOLIC REGULATION; NONHUMAN; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PYRUVATE CARBOXYLASE DEFICIENCY; REPERFUSION INJURY; TREATMENT OUTCOME; UREA CYCLE;

ACYL COENZYME A; ANIMALS; CITRIC ACID CYCLE; GLUTAMIC ACID; GLUTAMINE; HEPTANOATES; HUMANS; KETONE BODIES; METABOLISM, INBORN ERRORS; PROPIONIC ACIDS; PYRUVIC ACID; REPERFUSION INJURY; TRIGLYCERIDES; VALERATES;

EID: 33745105118     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-006-0320-1     Document Type: Article

References (27)

1. Aragon JJ, Tornheim K, Goodman MN, Lowenstein JM (1981) Replenishment of citric acid cycle intermediates by the purine nucleotide cycle in rat skeletal muscle. Curr Top Cell Regul 18: 131-149.
2. Ardawi MS, Newsholme EA (1982) Maximum activities of some enzymes of glycolysis, the tricarboxylic acid cycle and ketone-body and glutamine utilization pathways in lymphocytes of the rat. Biochem J 208: 743-748.
3. Bassenge E, Sommer O, Schwemmer M, Bunger R (2000) Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state. Am J Physiol Heart Circ Physiol 279: H2431-H2438.
4. Birkhahn RH, Border JR (1978) Intravenous feeding of the rat with short chain fatty acid esters. II. Monoacetoacetin. Am J Clin Nutr 31: 436-441.
5. Brunengraber H, Boutry M, Lowenstein JM (1973) Fatty acid and 3-β -hydroxysterol synthesis in the perfused rat liver. Including measurements on the production of lactate, pyruvate, β-hydroxy-butyrate, and acetoacetate by the fed liver. J Biol Chem 248: 2656-2669.
6. Bunger R, Swindall B, Brodie D, Zdunek D, Stiegler H, Walter G (1986) Pyruvate attenuation of hypoxia damage in isolated working guinea-pig heart. J Mol Cell Cardiol 18: 423-438.
7. Hermann HP, Arp J, Pieske B, et al (2004) Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure. Eur J Heart Fail 6: 213-218.
8. Jessen ME, Kovarik TE, Jeffrey FM, et al (1993) Effects of amino acids on substrate selection, anaplerosis, and left ventricular function in the ischemic reperfused rat heart. J Clin Invest 92: 831-839.
9. Kasumov T, Cendrowski A, David F, Jobbins K, Anderson VE, Brunengraber H (2006) Anaplerosis from propionate inhibits protein catabolism in the perfused rat heart. FASEB J 20: A740 (Abstract 468.7).
10. Khogali SE, Harper AA, Lyall JA, Rennie MJ (1998) Effects of l-glutamine on postischaemic cardiac function: Protection and rescue. J Mol Cell Cardiol 30: 819-827.
11. Krebs, HA, Hems R, Weidemann MJ, et al (1966) The fate of isotopic carbon in kidney cortex synthesizing glucose from lactate. Biochem J 101: 242-249.
12. Kristo G, Yoshimura Y, Niu J, et al (2004) The intermediary metabolite pyruvate attenuates stunning and reduces infarct size in in vivo porcine myocardium. Am J Physiol Heart Circ Physiol 286: H517-H524.
13. Leclerc J, Des Rosiers C, Montgomery JA, et al (1995) Metabolism of R -beta-hydroxypentanoate and of beta-ketopentanoate in conscious dogs. Am J Physiol 268: E446-E452.
14. MacDonald MJ, Fahien LA, Brown LJ, Hasan NM, Buss JD, Kendrick MA (2005) Perspective: Emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion. Am J Physiol Endocrinol Metab 288: E1-E15.
15. McGarry JD, Foster DW (1980) Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 49: 395-420.
16. Mentzer RM Jr, Van Wylen DG, Sodhi J, et al (1989) Effect of pyruvate on regional ventricular function in normal and stunned myocardium. Ann Surg 209: 629-633.
17. Mochel F, DeLonlay P, Touati G, et al (2005) Pyruvate carboxylase deficiency: Clinical and biochemical response to anaplerotic diet therapy. Mol Genet Metab 84: 305-312.
18. Puchowicz MA, Bederman IR, Comte B, et al (1999) Zonation of acetate labeling across the liver: Implications for studies of lipogenesis by MIDA. Am J Physiol 277: E1022-E1027.
19. Reszko AE, Kasumov T, Pierce BA, et al (2003) Assessing the reversibility of the anaplerotic reactions of the propionyl-CoA pathway in heart and liver. J Biol Chem 278: 34959-34965.
20. Roe CR, Mochel F (2006) Anaplerotic diet therapy in inherited metabolic diseases: Therapeutic potential. J Inherit Metab Dis 29: 332-340.
21. Roe CR, Sweetman L, Roe DS, David F, Brunengraber H (2002) Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 110: 259-269.
22. Russell RR III, Taegtmeyer H (1991) Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate. Am J Physiol 261: H1756-H1762.
23. Russell RR III, Mommessin JI, Taegtmeyer H (1995) Propionyl-l-carnitine-mediated improvement in contractile function of rat hearts oxidizing acetoacetate. Am J Physiol 268: H441-H447.
24. 13C]glucose infusion J Neurochem 76: 975-989.
25. Stanley WC, Kivilo KM, Panchal AR, et al (2003) Post-ischemic treatment with dipyruvyl-acetyl-glycerol decreases myocardial infarct size in the pig. Cardiovasc Drugs Ther 17: 209-216.
26. Williamson JR, Scholz R, Browning ET (1969) Control mechanisms of gluconeogenesis and ketogenesis. II. Interactions between fatty acid oxidation and the citric acid cycle in perfused rat liver. J Biol Chem 244: 4617-4627.
27. Yu L, Kasumov T, Jobbins K, et al (2006) The anaplerotic potential of pentanoate and β-ketopentanoate in pig heart in vivo. FASEB J 20: A862 (Abstract 530.8).